Fortress biotech, inc. (FBIO)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Dec'10
ASSETS
Current assets
Cash and cash equivalents

135,943

136,858

134,945

149,407

116,444

65,508

95,867

98,591

124,020

94,952

110,536

144,344

134,037

88,294

82,537

71,336

81,415

98,182

25,563

41,037

48,928

49,759

71,592

75,798

79,982

99,521

106,267

67,886

44,052

40,199

47,478

38,207

17,735

23,160

26,708

14,862

Accounts receivable (net of allowance for doubtful accounts of $0 and $100 at March 31, 2020 and December 31, 2019, respectively)

15,810

13,539

5,137

3,104

8,022

5,498

5,431

5,321

8,314

7,758

5,582

3,336

1,368

1,830

5,007

967

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities, at fair value (Note 3)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

39,951

20,000

20,005

20,002

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Short-term investments (certificates of deposit)

-

-

5,000

5,000

5,044

17,604

22,538

35,000

37,002

36,002

44,088

20,038

-

0

-

-

-

-

-

-

-

-

52

295

-

-

-

-

-

-

-

-

-

-

-

-

Cash deposits with clearing organizations

-

-

-

-

-

-

336

836

1,041

-

1,040

1,040

1,030

1,030

1,030

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Receivables from broker-dealers and clearing organizations

-

-

-

-

-

-

11,884

11,412

8,464

-

8,282

2,813

2,858

3,357

1,607

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Forgivable loans receivable

-

-

-

-

-

-

1,610

1,598

1,534

-

1,269

1,397

1,528

1,712

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Securities owned, at fair value

-

-

-

-

-

-

6,675

3,812

4,278

-

1,595

3,406

1,206

2,357

2,178

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

769

857

941

732

629

678

674

299

222

171

318

299

204

203

123

100

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other receivables - related party

1,753

865

1,243

1,850

2,129

2,095

414

775

944

618

638

1,605

1,034

1,790

1,545

2,570

1,314

156

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

4,526

4,133

4,117

3,418

4,281

6,735

14,089

13,880

14,338

5,732

10,739

11,902

8,542

9,061

4,556

1,579

1,607

1,599

1,096

997

680

702

428

386

522

510

279

243

1,010

393

517

286

308

215

98

55

Restricted cash, current

-

-

14,929

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current assets held for sale

-

-

-

-

-

13,089

-

-

-

37,948

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current assets

158,801

156,252

166,312

163,511

136,549

111,207

159,518

171,524

200,157

183,181

184,087

190,180

151,807

109,634

98,583

76,552

84,336

99,937

66,610

62,034

69,613

70,463

72,072

76,479

80,504

100,031

106,546

68,129

45,062

40,592

47,995

38,493

18,043

23,375

26,806

14,917

Property and equipment, net

12,785

12,433

12,152

12,023

11,833

12,019

14,642

14,163

12,278

7,116

8,221

7,329

7,386

7,376

6,957

4,535

2,598

309

129

90

46

52

58

63

69

447

452

535

50

51

-

-

-

0

-

22

Operating lease right-of-use asset, net

21,076

21,480

21,876

22,255

22,618

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

16,574

16,574

1,145

16,074

16,074

16,074

17,358

17,389

17,387

16,006

16,886

15,860

15,860

15,860

15,859

14,586

14,586

14,586

14,586

14,586

14,586

14,586

15,446

14,009

14,009

0

-

-

-

-

-

-

-

-

-

-

Long-term investment, at fair value

11,148

11,148

11,193

11,193

11,056

0

0

565

1,272

1,390

923

903

746

1,414

685

766

1,567

2,485

4,095

5,567

3,945

4,160

250

250

250

0

-

-

-

-

-

-

-

-

-

-

Intangible asset, net

7,022

7,377

7,731

971

1,183

1,417

13,935

13,614

14,400

883

15,983

16,533

17,077

17,408

1,550

1,579

1,450

1,250

1,250

1,250

1,250

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

-

-

-

-

-

-

18,645

18,645

18,645

-

18,645

18,645

18,645

18,645

21,739

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

1,353

1,158

1,179

1,237

1,225

276

821

966

936

258

346

396

390

394

48

44

376

43

194

172

1,011

64

181

69

70

104

109

-

-

349

-

-

-

-

-

-

Noncurrent assets held for sale

-

-

-

-

-

-

-

-

-

37,116

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

114

344

-

90

-

-

-

-

-

Total assets

228,759

226,422

221,588

227,264

200,538

140,993

224,919

236,866

265,075

245,950

245,091

249,846

211,911

170,731

145,421

98,062

104,913

118,610

86,864

83,699

90,451

89,325

88,007

90,870

94,902

100,582

107,107

68,778

45,456

40,992

48,085

38,493

18,043

23,375

26,806

14,939

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable and accrued expenses

34,200

35,451

28,512

24,260

37,073

34,067

37,345

38,126

44,725

27,412

31,978

24,995

24,864

24,295

21,831

-

-

10,438

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses - related party

-

-

-

-

16

-

153

73

124

222

88

78

96

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued commissions and payroll payable

-

-

-

-

-

-

11,974

10,652

10,713

-

11,255

11,613

10,190

11,940

14,029

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred clearing and marketing credits

-

-

-

-

-

-

629

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred clearing and marketing credits

-

-

-

-

-

-

-

681

733

-

838

891

943

995

1,007

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred product revenue

-

-

-

-

-

-

-

-

-

-

680

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Securities sold, not yet purchased, at fair value

-

-

-

-

-

-

24

8

0

-

0

77

1

298

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration payable

-

-

-

-

-

-

-

-

-

-

637

630

623

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrants issued - National

-

-

-

-

-

-

0

0

6,671

-

8,832

8,190

10,096

14,359

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,126

2,348

-

1,287

583

664

366

333

331

872

468

1,114

1,429

676

1,029

840

753

1,001

575

902

476

Accounts payable and accrued expenses - related party

13

-

-

-

-

149

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

48

46

PCP interest payable-related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19

19

-

19

-

Accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,883

8,259

-

7,137

4,386

5,238

3,683

3,199

3,081

3,438

4,430

2,352

2,797

2,183

2,185

3,509

3,154

2,823

2,899

1,554

1,037

Interest payable - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19

-

-

Interest payable

1,081

1,042

1,039

1,022

1,013

1,232

613

1,143

332

315

161

142

89

88

68

26

27

27

26

26

26

28

25

25

25

109

116

116

119

119

116

-

-

-

-

-

Interest payable - related party

53

92

89

94

97

97

94

94

657

669

497

326

-

77

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Notes payable, short-term (net of debt discount of $0 at March 31, 2020 and December 31, 2019)

14,522

7,220

15,472

9,396

9,277

9,164

-

-

-

8,528

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Notes payable, short-term (net of debt discount of $447 and $973 at September 30, 2018 and December 31, 2017, respectively)

-

-

-

-

-

-

9,054

0

0

-

8,223

3,007

2,105

1,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Partner company convertible note, short-term, at fair value

-

-

-

-

-

9,914

10,657

10,573

12,651

4,700

4,733

3,211

3,147

1,031

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities - short-term

1,794

1,784

1,741

1,626

1,481

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

155

650

690

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingently issuable liabilities

-

-

-

-

-

-

-

-

-

-

0

0

0

1,682

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative warrant liability

69

27

-

-

-

991

0

0

78

309

313

91

402

481

951

302

203

114

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current liabilities held for sale

-

-

-

-

-

-

-

-

-

29,283

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current liabilities

-

-

-

-

-

-

77

158

1,952

-

193

217

244

319

707

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

6,203

6,062

4,611

3,190

1,799

-

-

-

-

-

-

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,170

-

Total current liabilities

51,732

45,616

46,853

36,398

48,957

55,614

70,775

62,158

79,326

71,438

68,428

53,468

52,800

56,565

38,593

14,337

10,837

10,579

8,450

4,995

5,928

4,077

3,557

3,437

4,335

11,210

9,644

8,953

6,168

5,132

4,465

3,926

3,843

3,493

3,693

1,559

PCP notes payable-related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

750

750

750

750

-

Notes payable, long-term (net of debt discount of $4,354 and $5,086 at March 31, 2020 and December 31, 2019, respectively)

70,866

77,436

68,542

74,307

73,607

60,425

64,546

73,456

73,444

39,212

40,734

39,274

26,137

22,528

24,373

20,805

20,751

23,174

23,291

23,232

24,009

14,003

14,009

14,009

14,009

7,017

8,408

9,760

11,086

12,386

14,094

-

-

-

-

-

Operating lease liabilities - long-term

23,647

23,712

24,168

24,510

24,989

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Partner company convertible note, long-term, at fair value

-

-

-

-

-

-

0

0

0

10,059

9,928

1,462

1,637

3,656

3,031

1,000

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

7,229

7,126

7,025

2,229

2,276

5,211

4,961

4,987

4,759

4,739

4,736

5,026

5,020

5,014

4,583

3,706

2,416

584

202

264

327

722

-

-

1,066

1,077

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,181

1,056

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,541

1,507

1,474

1,441

-

-

-

-

-

-

Other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

398

-

-

-

-

-

Total liabilities

153,474

153,890

146,588

137,444

149,829

121,250

140,282

140,601

157,529

125,448

123,826

99,230

85,594

87,763

70,580

39,848

34,004

34,337

31,943

28,491

30,264

18,802

18,747

18,502

19,410

19,304

19,593

20,220

18,728

18,959

18,957

4,676

4,593

4,243

4,443

1,559

Commitments and contingencies

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders' equity
Preferred stock, $.001 par value, 15,000,000 authorized, 5,000,000 designated Series A shares, 2,059,917 and 1,341,167 shares issued as of March 31, 2020 and December 31, 2019, respectively; 2,054,917 and 1,341,167 shares outstanding as of March 31, 2020 and December 31, 2019, respectively; liquidation value of $25.00 per share

2

1

1

1

1

1

1

1

1

1

-

-

-

0

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Convertible Preferred stock, $.001 par value, 129,767 Series C shares authorized, 0 shares issued and outstanding as of both March 31, 2014 and December 31, 2013

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

29,277

Convertible Preferred Stock, $.001 par value, 461,263 Series C Shares authorized, 0 shares issued and outstanding as of March 31, 2012 and December 31, 2011, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

Common stock, $.001 par value, 100,000,000 shares authorized, 78,572,169 and 74,027,425 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

79

74

70

68

63

58

56

54

52

51

51

50

50

49

49

49

49

47

47

47

47

46

44

44

44

40

35

30

26

24

24

24

19

19

7

5

Common stock issuable, 489,095 and 251,337 shares as of March 31, 2020 and December 31, 2019, respectively

661

500

500

490

765

659

495

776

489

500

353

189

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Treasury stock

70

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Additional paid-in-capital

485,160

461,874

445,966

439,295

414,870

397,408

408,615

397,858

374,254

364,148

338,254

346,630

304,929

283,697

264,397

250,127

246,877

246,955

231,684

215,793

213,890

212,205

207,231

205,747

204,160

202,580

199,023

152,240

119,744

106,193

104,623

103,378

76,561

75,687

5,206

4,312

Accumulated deficit

-448,604

-436,234

-420,742

-407,980

-394,882

-396,274

-371,394

-354,756

-333,145

-312,127

-301,714

-274,598

-257,233

-245,251

-227,820

-214,839

-202,361

-190,156

-178,120

-159,959

-153,784

-141,728

-138,015

-133,423

-128,712

-121,342

-111,544

-103,712

-93,042

-84,184

-75,519

-69,585

-63,130

-56,574

-49,855

-20,214

Total stockholders' equity attributed to the Company

37,228

26,215

25,795

31,874

20,817

1,852

37,773

43,933

41,651

52,573

36,944

72,271

47,746

38,495

36,626

35,337

44,565

56,846

53,611

55,881

60,187

70,523

69,260

72,368

75,492

81,278

87,514

48,558

26,728

22,033

29,128

33,817

13,450

19,132

-44,642

-15,897

Non-controlling interests

38,057

46,317

49,205

57,946

29,892

17,891

46,864

52,332

65,895

67,929

84,321

78,345

78,571

44,473

38,215

22,877

26,344

27,427

1,310

-673

34

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total stockholders' equity

75,285

72,532

75,000

89,820

50,709

19,743

84,637

96,265

107,546

120,502

121,265

150,616

126,317

82,968

74,841

58,214

70,909

84,273

54,921

55,208

60,153

70,523

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities and stockholders' equity

228,759

226,422

221,588

227,264

200,538

140,993

224,919

236,866

265,075

245,950

245,091

249,846

211,911

170,731

145,421

98,062

104,913

118,610

86,864

83,699

90,451

89,325

88,007

90,870

94,902

100,582

107,107

68,778

45,456

40,992

48,085

38,493

18,043

23,375

26,806

14,939